Review of the vaginal contraceptive ring (NuvaRing)

J Fam Plann Reprod Health Care. 2008 Oct;34(4):247-50. doi: 10.1783/147118908786000370.

Abstract

NuvaRing represents another useful contraceptive option for women. The vaginal administration confers benefits and women do not appear to dislike this route of hormone delivery. Efficacy and cycle control are the least comparable to conventional COCs and adverse events are minimal, though vaginal side effects are reported more commonly. Women may find that trying to insert the ring in the clinic will allay any concerns they have with regard to insertion and removal.

Publication types

  • Review

MeSH terms

  • Contraceptive Agents, Female / pharmacology
  • Contraceptive Agents, Female / therapeutic use*
  • Desogestrel / analogs & derivatives
  • Desogestrel / pharmacology
  • Desogestrel / therapeutic use
  • Drug Combinations
  • Ethinyl Estradiol / pharmacology
  • Ethinyl Estradiol / therapeutic use
  • Female
  • Humans
  • Menstrual Cycle / drug effects
  • Patient Satisfaction

Substances

  • Contraceptive Agents, Female
  • Drug Combinations
  • NuvaRing
  • Ethinyl Estradiol
  • Desogestrel